Neurocrine Biosciences, Inc.
DE ˙ DB ˙ US64125C1099
134,65 € ↑0,30 (0,22%)
2026-06-03
AKTIENPREIS
SecurityDE:NB3 / Neurocrine Biosciences, Inc.
InstitutionDe Burlo Group Inc
Latest Disclosed Ownership4,667 shares
Latest Disclosed Value $ 614,831
De Burlo Group Inc ownership in NB3 / Neurocrine Biosciences, Inc.

On May 14, 2026 - De Burlo Group Inc filed a 13F-HR form disclosing ownership of 4,667 shares of Neurocrine Biosciences, Inc. (DE:NB3) valued at $521,537 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 4,667 shares of Neurocrine Biosciences, Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $628,412 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 4,667 0 0.00 615 -7.11 0.1393
2026-02-13 2025-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 4,667 -100 -2.10 662 -1.20 0.0803
2025-11-13 2025-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 4,767 100 2.14 669 14.16 0.0806
2025-08-13 2025-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 4,667 -50 -1.06 587 12.48 0.0773
2025-05-07 2025-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 4,717 100 2.17 522 -17.30 0.0770
2025-02-14 2024-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 4,617 -500 -9.77 630 6.96 0.0841
2024-11-12 2024-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 5,117 0 0.00 590 -16.34 0.0726
2024-08-14 2024-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 5,117 -50 -0.97 704 -1.12 0.0947
2024-05-13 2024-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 5,167 -4,000 -43.63 713 -30.94 0.0946
2024-02-13 2023-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 9,167 0 0.00 1,031 0.00 0.1792
2023-11-13 2023-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 9,167 0 0.00 1,031 19.33 0.1792
2023-08-14 2023-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 9,167 0 0.00 864 -6.80 0.1438
2023-05-15 2023-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 9,167 0 0.00 928 -15.27 0.1812
2023-02-14 2022-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 9,167 0 0.00 1,095 -99.89 0.2447
2022-11-14 2022-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 9,167 9,167 973,627 0.2318
2022-08-11 2022-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -9,333 -100.00 0 -100.00
2022-05-16 2022-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 9,333 -1,450 -13.45 874,969 95,212.53 0.1629
2022-01-28 2021-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 10,783 -700 -6.10 918 -16.62 0.1333
2021-11-09 2021-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 11,483 0 0.00 1,101 -1.43 0.1784
2021-08-05 2021-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 11,483 0 0.00 1,117 0.00 0.1777
2021-05-06 2021-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 11,483 -100 -0.86 1,117 0.63 0.1999
2021-02-05 2020-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 11,583 -300 -2.52 1,110 -2.89 0.1815
2020-11-05 2020-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 11,883 133 1.13 1,143 12.39 0.2077
2020-08-06 2020-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 11,750 0 0.00 1,017 0.00 0.2850
2020-05-07 2020-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 11,750 -300 -2.49 1,017 -21.47 0.2850
2020-02-06 2019-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 12,050 -300 -2.43 1,295 16.35 0.2617
2019-11-07 2019-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 12,350 0 0.00 1,113 6.71 0.2506
2019-08-07 2019-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 12,350 -300 -2.37 1,043 -6.37 0.2037
2019-05-09 2019-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 12,650 -3,650 -22.39 1,114 -4.21 0.2248
2019-02-07 2018-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 16,300 -600 -3.55 1,163 -44.03 0.2611
2018-11-08 2018-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 16,900 0 0.00 2,078 25.18 0.3898
2018-08-10 2018-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 16,900 0 0.00 1,660 18.49 0.3514
2018-05-03 2018-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 16,900 0 0.00 1,401 6.86 0.3050
2018-02-08 2017-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 16,900 -800 -4.52 1,311 20.94 0.2656
2017-11-02 2017-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 17,700 -4,650 -20.81 1,084 5.45 0.2402
2017-08-03 2017-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 22,350 -5,300 -19.17 1,028 -14.12 0.2294
2017-05-04 2017-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 27,650 -23,800 -46.26 1,197 -39.88 0.2598
2017-02-10 2016-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 51,450 -1,000 -1.91 1,991 -25.04 0.4847
2016-11-10 2016-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 52,450 0 0.00 2,656 11.46 0.7368
2016-08-04 2016-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 52,450 0 0.00 2,383 14.90 0.5761
2016-05-05 2016-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 52,450 -900 -1.69 2,074 -31.28 0.5999
2016-02-04 2015-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 53,350 0 0.00 3,018 42.22 0.7102
2015-11-05 2015-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 53,350 -4,000 -6.97 2,122 -22.53 0.4981
2015-08-07 2015-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 57,350 -1,000 -1.71 2,739 18.21 0.5733
2015-05-07 2015-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 58,350 -3,000 -4.89 2,317 69.12 0.4587
2015-02-12 2014-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 61,350 -200 -0.32 1,370 42.12 0.2770
2014-11-07 2014-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 61,550 -2,400 -3.75 964 1.58 0.2131
2014-08-01 2014-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 63,950 -1,700 -2.59 949 -10.22 0.2148
2014-05-08 2014-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 65,650 24,300 58.77 1,057 173.83 0.2549
2014-02-11 2013-12-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 41,350 -7,400 -15.18 386 -30.07 0.0921
2014-02-07 2013-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 41,350 2,091
2013-11-08 2013-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 48,750 48,750 552 0.1503
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.